Amivantamab Injection Solutions (Rybrevant®) for the period 01.09.2026–31.12.2027
Status
Active
Submission Deadline
183 days remaining
Contracting authority
Varsinais-Suomen hyvinvointialue — Tyks sairaala-apteekki1 more open tender view
Location
Finland
Procedure
Negotiated procedure without prior call for competition · Supplies
Category
Pharmaceutical products.
Published
Reference
hilma-EF-54926
Source
Direct procurement of Amivantamab injection solutions (Rybrevant®) in strengths of 1,600 mg, 2,240 mg, 2,400 mg, and 3,520 mg for the pharmaceutical procurement ring of the Varsinais-Suomi wellbeing services county; contract period from 01.09.2026 to 31.12.2027.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Additional details
Electronic Submission
Required
Legal Basis
32014L0024